These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6047760)
1. The drug treatment of leprosy. Browne SG Trans R Soc Trop Med Hyg; 1967; 61(2):265-71. PubMed ID: 6047760 [No Abstract] [Full Text] [Related]
2. [On the chemoresistance of the Hansen bacillus and the treatment of leprosy with drug associations]. Floch HA Bull Soc Pathol Exot Filiales; 1966; 59(2):188-92. PubMed ID: 6012833 [No Abstract] [Full Text] [Related]
3. Experimental chemotherapy in leprosy, then and now. Shepard CC Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732 [No Abstract] [Full Text] [Related]
4. Chemotherapy of leprosy. Shepard CC Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433 [No Abstract] [Full Text] [Related]
8. The treatment of leprosy and its acute complications. Jopling WH Trop Doct; 1973 Jan; 3(1):8-11. PubMed ID: 4120944 [No Abstract] [Full Text] [Related]
9. Further observations on streptomycin combined with sulfones in relapsed lepromatous leprosy. Hastings RC; Trautman JR; Mansfield RE Int J Lepr Other Mycobact Dis; 1969; 37(2):130-4. PubMed ID: 5389014 [No Abstract] [Full Text] [Related]
10. Six years follow-up of diphenylthiourea treatment. Davison AR Lepr Rev; 1965 Jul; 36(3):145-6. PubMed ID: 5871245 [No Abstract] [Full Text] [Related]
11. The drug treatment of leprosy. Browne SG Practitioner; 1975 Oct; 215(1288):493-500. PubMed ID: 1202470 [No Abstract] [Full Text] [Related]
12. Use of "Novolep", a by-product of D.D.S., for the treatment of trophic ulcers (planter) in leprosy. Mahapatra SB Indian J Dermatol; 1975 Oct; 21(1):22-4. PubMed ID: 1234880 [No Abstract] [Full Text] [Related]
13. Patient compliance with dapsone administration in leprosy. Huikeshoven H Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150 [No Abstract] [Full Text] [Related]
14. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance. Pearson JM; Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115 [No Abstract] [Full Text] [Related]
15. The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy. Waters MF; Rees RJ; Laing AB; Khoo Kah Fah ; Meade TW; Parikshak N; North WR Lepr Rev; 1986 Jun; 57(2):101-9. PubMed ID: 3747702 [No Abstract] [Full Text] [Related]
16. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029 [No Abstract] [Full Text] [Related]
17. Chemotherapy of leprosy. Leiker DL Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084 [No Abstract] [Full Text] [Related]
18. A survey of the drugs with activity against M. leprae in mice. Shepard CC Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080 [No Abstract] [Full Text] [Related]
19. Repository acedapsone in leprosy chemoprophylaxis and treatment. Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC Lancet; 1971 Sep; 2(7723):525-6. PubMed ID: 4105668 [No Abstract] [Full Text] [Related]
20. Controlled trials in the chemotherapy of leprosy. Long ER Int J Lepr Other Mycobact Dis; 1967; 35(3):388-91. PubMed ID: 4917110 [No Abstract] [Full Text] [Related] [Next] [New Search]